aTYR PHARMA (ATYR) Change in Cash (2014 - 2026)

aTYR PHARMA (ATYR) has 13 years of Change in Cash data on file, last reported at -$1.2 million in Q1 2026.

• Quarterly Change in Cash rose 3.88% year-over-year to -$1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$981000.0 (down 135.39% YoY) and the FY2025 annual result came in at -$1.0 million, up 91.45% from the prior year.
• Change in Cash slipped to -$1.2 million in Q1 2026, from $4.1 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $12.8 million in Q4 2023 to a low of -$16.0 million in Q1 2024.
• A 5-year average of $557470.6 and a median of -$321000.0 in 2024 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2023 — Change in Cash slumped 1012.43% — and 2025, when it surged 2375.39%.
• Tracing ATYR's Change in Cash over 5 years: stood at -$7.5 million in 2022, then jumped by 271.63% to $12.8 million in 2023, then tumbled by 102.96% to -$378000.0 in 2024, then jumped by 1188.89% to $4.1 million in 2025, then plunged by 128.3% to -$1.2 million in 2026.
• The last three Change in Cash figures came in at -$1.2 million (Q1 2026), $4.1 million (Q4 2025), and -$11.2 million (Q3 2025), per Business Quant data.